The National Agency for Food and Drug Administration and Control (NAFDAC) has warned about the possible distribution of fake Augmentin 625mg Tabs in the nation.
The regulatory body claimed the medicine didn't comply with labelling rules in a statement titled "NAFDAC Alert And Sensitization Of The Public On Suspected Falsified Augmentin 625mg."
The statement stated that the allegedly fabricated Augmentin, produced in April 2021, would expire in April 2024. The batch number of the fake medicine, 562626, and its NAFDAC registration number, 04-1928, were also mentioned.
ALERT AND SENSITIZATION ON SUSPECTED FALSIFIED AUGMENTIN 625MG#NafdacALERTS
Read here 🔗 https://t.co/yIja3NyGqw pic.twitter.com/KWkX6Jtbyy
— NAFDAC NIGERIA (@NafdacAgency) October 23, 2022“The product failed short of the labeling requirements. No inscription “manufactured by” is written on the label -only the address,” the agency said.
“Manufacturing and expiry dates do not meet the acceptable format. No MAS scratch number for verification.
“The logo “gsk” is not correctly positioned as on the original. The listed information indicates the product is falsified and counterfeited.
“In view of the above, NAFDAC has notified all its formations in the zones and 36 states of the federation including the FCT to carry out surveillance and mop up the falsified Augmentin tablets.”
It added, “Please note that the genuine Augmentin 625mg has legible product labelling information including date markings – expiration and manufactured dates, batch number, and NAFDAC registration number.
“NAFDAC advises wholesalers, distributors, and pharmacies is that medicines should be obtained from authorized/licensed suppliers, increased vigilance is hereby encouraged within the supply chain to avoid infiltration of the falsified product. The products’ authenticity, physical condition, and labels should be carefully checked.
“NAFDAC implores healthcare providers to ensure vigilance to prevent the administration of falsified products to unsuspecting patients. Members of the public in possession of the above suspected counterfeit product are advised to discontinue sale or use and submit stock to the nearest NAFDAC office.”
Members of the public in possession of the above suspected counterfeit product are advised to discontinue sale or use and submit stock to the nearest NAFDAC office.
— NAFDAC NIGERIA (@NafdacAgency) October 23, 2022